With A 67 percent Price Drop For Verrica Pharmaceuticals Inc. Youll Still Get What You Pay For

VRCA Stock  USD 0.87  0.01  1.14%   
About 56% of all Verrica Pharmaceuticals' investors are looking to take a long position. The analysis of overall sentiment of trading Verrica Pharmaceuticals stock suggests that some investors are interested at this time. The current market sentiment, together with Verrica Pharmaceuticals' historical and current headlines, can help investors time the market. In addition, many technical investors use Verrica Pharmaceuticals stock news signals to limit their universe of possible portfolio assets.
  
The Verrica Pharmaceuticals Inc. share price has fared very poorly over the last month, falling by a...

Read at simplywall.st
Simply Wall St News at Macroaxis
  

Verrica Pharmaceuticals Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards Verrica Pharmaceuticals can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Verrica Pharmaceuticals Fundamental Analysis

We analyze Verrica Pharmaceuticals' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Verrica Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Verrica Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Total Asset

Total Asset Comparative Analysis

Verrica Pharmaceuticals is currently under evaluation in total asset category among its peers. Total Asset is everything that a business owns. It is the sum of current and long-term assets owned by a firm at a given time. These assets are listed on a balance sheet and typically valued based on their purchasing prices, not the current market value.

Verrica Pharmaceuticals Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Verrica Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Verrica Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Verrica Pharmaceuticals by comparing valuation metrics with similar companies.

Peers

Verrica Pharmaceuticals Related Equities

CNTBConnect Biopharma   7.89   
0%
100.0%
CRNXCrinetics Pharmaceuticals   5.21   
0%
66.0%
ASNDAscendis Pharma   3.56   
0%
45.0%
VRNAVerona Pharma   1.29   
0%
16.0%
EWTXEdgewise Therapeutics   1.15   
0%
14.0%
ABOSAcumen Pharmaceuticals   0.46   
0%
5.0%
ETONEton Pharmaceuticals   0.25   
0%
3.0%
FENCFennec Pharmaceuticals   0.16   
0%
2.0%
LRMRLarimar Therapeutics   1.07   
13.0%
0%
NUVBNuvation Bio   1.11   
14.0%
0%
PLXProtalix Biotherapeutics   1.64   
20.0%
0%
PLRXPliant Therapeutics   2.20   
27.0%
0%
IVAInventiva   2.32   
29.0%
0%
VIGLVigil Neuroscience   2.67   
33.0%
0%
ARQTArcutis Biotherapeutics   2.89   
36.0%
0%
ELDNEledon Pharmaceuticals   3.11   
39.0%
0%

Complementary Tools for Verrica Stock analysis

When running Verrica Pharmaceuticals' price analysis, check to measure Verrica Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Verrica Pharmaceuticals is operating at the current time. Most of Verrica Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Verrica Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Verrica Pharmaceuticals' price. Additionally, you may evaluate how the addition of Verrica Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Bonds Directory
Find actively traded corporate debentures issued by US companies
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities